News
INVO
0.7550
-4.43%
-0.0350
Weekly Report: what happened at INVO last week (0826-0830)?
Weekly Report · 6d ago
Weekly Report: what happened at INVO last week (0819-0823)?
Weekly Report · 08/26 10:36
Weekly Report: what happened at INVO last week (0812-0816)?
Weekly Report · 08/19 10:27
INVO BioScience GAAP EPS of -$0.62, revenue of $1.84M
Seeking Alpha · 08/15 16:14
INVO Stock Earnings: INVO Bioscience Reported Results for Q2 2024
Investorplace · 08/15 02:56
Based on the provided financial report articles, I generated the title for the article: "INVO Bioscience, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2024" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content, I inferred the title to be related to the financial results of INVO Bioscience, Inc. for the second quarter ended June 30, 2024.
Press release · 08/14 14:50
Press Release: INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
Dow Jones · 08/14 13:00
Weekly Report: what happened at INVO last week (0805-0809)?
Weekly Report · 08/12 10:29
Weekly Report: what happened at INVO last week (0729-0802)?
Weekly Report · 08/05 10:36
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 07/30 17:53
Weekly Report: what happened at INVO last week (0722-0726)?
Weekly Report · 07/29 10:29
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 07/29 09:26
Weekly Report: what happened at INVO last week (0715-0719)?
Weekly Report · 07/22 10:30
Weekly Report: what happened at INVO last week (0708-0712)?
Weekly Report · 07/15 10:27
Weekly Report: what happened at INVO last week (0701-0705)?
Weekly Report · 07/08 10:28
Weekly Report: what happened at INVO last week (0624-0628)?
Weekly Report · 07/01 10:29
Weekly Report: what happened at INVO last week (0617-0621)?
Weekly Report · 06/24 10:34
INVO BIOSCIENCE: ON JUNE 18, 2024, CO RECEIVED NOTICE FROM NASDAQ INFORMING CO WAS GRANTED REQUEST FOR CONTINUED LISTING ON NASDAQ
Reuters · 06/20 20:22
Weekly Report: what happened at INVO last week (0610-0614)?
Weekly Report · 06/17 10:28
Weekly Report: what happened at INVO last week (0603-0607)?
Weekly Report · 06/10 10:29
More
Webull provides a variety of real-time INVO stock news. You can receive the latest news about Invo Bioscience Inc through multiple platforms. This information may help you make smarter investment decisions.
About INVO
INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.